|
1
|
Prall F: Tumour budding in colorectal
carcinoma. Histopathology. 50:151–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thomson S, Buck E, Petti F, Griffin G,
Brown E, Ramnarine N, Iwata KK, Gibson N and Haley JD: Epithelial
to mesenchymal transition is a determinant of sensitivity of
non-small-cell lung carcinoma cell lines and xenografts to
epidermal growth factor receptor inhibition. Cancer Res.
65:9455–9462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kurrey NK, Jalgaonkar SP, Joglekar AV,
Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA: Snail and slug
mediate radioresistance and chemoresistance by antagonizing
p53-mediated apoptosis and acquiring a stem-like phenotype in
ovarian cancer cells. Stem Cells. 27:2059–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JK, Joo KM, Lee J, Yoon Y and Nam DH:
Targeting the epithelial to mesenchymal transition in glioblastoma:
The emerging role of MET signaling. Onco Targets Ther. 7:1933–1944.
2014.PubMed/NCBI
|
|
6
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gavert N and Ben-Ze'ev A:
Epithelial-mesenchymal transition and the invasive potential of
tumors. Trends Mol Med. 14:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grände M, Franzen A, Karlsson JO, Ericson
LE, Heldin NE and Nilsson M: Transforming growth factor-beta and
epidermal growth factor synergistically stimulate epithelial to
mesenchymal transition (EMT) through a MEK-dependent mechanism in
primary cultured pig thyrocytes. J Cell Sci. 115:4227–4236. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen XF, Zhang HJ, Wang HB, Zhu J, Zhou
WY, Zhang H, Zhao MC, Su JM, Gao W, Zhang L, et al: Transforming
growth factor-β1 induces epithelial-to-mesenchymal transition in
human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling
pathways. Mol Biol Rep. 39:3549–3556. 2012. View Article : Google Scholar
|
|
12
|
Shirakihara T, Horiguchi K, Miyazawa K,
Ehata S, Shibata T, Morita I, Miyazono K and Saitoh M: TGF-β
regulates isoform switching of FGF receptors and
epithelial-mesenchymal transition. EMBO J. 30:783–795. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shih JY and Yang PC: The EMT regulator
slug and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan
ZK, Liu K and Huang S: Extracellular signal-regulated kinase
signaling pathway regulates breast cancer cell migration by
maintaining slug expression. Cancer Res. 69:9228–9235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau MT and Leung PC: The PI3K/Akt/mTOR
signaling pathway mediates insulin-like growth factor 1-induced
E-cadherin down-regulation and cell proliferation in ovarian cancer
cells. Cancer Lett. 326:191–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lyons JG, Patel V, Roue NC, Fok SY, Soon
LL, Halliday GM and Gutkind JS: Snail up-regulates proinflammatory
mediators and inhibits differentiation in oral keratinocytes.
Cancer Res. 68:4525–4530. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shintani Y, Okimura A, Sato K, Nakagiri T,
Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, et
al: Epithelial to mesenchymal transition is a determinant of
sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann
Thorac Surg. 92:1794–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marín-Aguilera M, Codony-Servat J, Reig Ò,
Lozano JJ, Fernández PL, Pereira MV, Jiménez N, Donovan M, Puig P,
Mengual L, et al: Epithelial-to-mesenchymal transition mediates
docetaxel resistance and high risk of relapse in prostate cancer.
Mol Cancer Ther. 13:1270–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kajiyama H, Shibata K, Terauchi M,
Yamashita M, Ino K, Nawa A and Kikkawa F: Chemoresistance to
paclitaxel induces epithelial-mesenchymal transition and enhances
metastatic potential for epithelial ovarian carcinoma cells. Int J
Oncol. 31:277–283. 2007.PubMed/NCBI
|
|
20
|
Yang AD, Fan F, Camp ER, van Buren G, Liu
W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuo W, Wang Y, Zhuo X, Zhang Y, Ao X and
Chen Z: Knockdown of Snail, a novel zinc finger transcription
factor, via RNA interference increases A549 cell sensitivity to
cisplatin via JNK/mitochondrial pathway. Lung Cancer. 62:8–14.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang TH, Tsai MF, Su KY, Wu SG, Huang CP,
Yu SL, Yu YL, Lan CC, Yang CH, Lin SB, et al: Slug confers
resistance to the epidermal growth factor receptor tyrosine kinase
inhibitor. Am J Respir Crit Care Med. 183:1071–1079. 2011.
View Article : Google Scholar
|
|
23
|
Sharma SV, Lee DY, Li B, Quinlan MP,
Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach
MA, et al: A chromatin-mediated reversible drug-tolerant state in
cancer cell subpopulations. Cell. 141:69–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sato M, Shames DS and Hasegawa Y: Emerging
evidence of epithelial-to-mesenchymal transition in lung
carcinogenesis. Respirology. 17:1048–1059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J,
Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, et al: Transforming
growth factor-β1 promotes lung adenocarcinoma invasion and
metastasis by epithelial-to-mesenchymal transition. Mol Cell
Biochem. 355:309–314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lamouille S, Connolly E, Smyth JW, Akhurst
RJ and Derynck R: TGF-β-induced activation of mTOR complex 2 drives
epithelial-mesenchymal transition and cell invasion. J Cell Sci.
125:1259–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buonato JM and Lazzara MJ: ERK1/2 blockade
prevents epithelial-mesenchymal transition in lung cancer cells and
promotes their sensitivity to EGFR inhibition. Cancer Res.
74:309–319. 2014. View Article : Google Scholar :
|
|
28
|
Ishikawa D, Takeuchi S, Nakagawa T, Sano
T, Nakade J, Nanjo S, Yamada T, Ebi H, Zhao L, Yasumoto K, et al:
mTOR inhibitors control the growth of EGFR mutant lung cancer even
after acquiring resistance by HGF. PLoS One. 8:e621042013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li L, Han R, Xiao H, Lin C, Wang Y, Liu H,
Li K, Chen H, Sun F, Yang Z, et al: Metformin sensitizes
EGFR-TKI-resistant human lung cancer cells in vitro and in vivo
through inhibition of IL-6 signaling and EMT reversal. Clin Cancer
Res. 20:2714–2726. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu HG, Wei W, Xia LH, Han WL, Zhao P, Wu
SJ, Li WD and Chen W: FBW7 upregulation enhances cisplatin
cytotoxicity in non-small cell lung cancer cells. Asian Pac J
Cancer Prev. 14:6321–6326. 2013. View Article : Google Scholar
|
|
31
|
Cufí S, Vazquez-Martin A,
Oliveras-Ferraros C, Martin-Castillo B, Joven J and Menendez JA:
Metformin against TGFβ-induced epithelial-to-mesenchymal transition
(EMT): From cancer stem cells to aging-associated fibrosis. Cell
Cycle. 9:4461–4468. 2010. View Article : Google Scholar
|
|
32
|
Cañadas I, Rojo F, Taus Á, Arpí O,
Arumí-Uría M, Pijuan L, Menéndez S, Zazo S, Dómine M, Salido M, et
al: Targeting epithelial-to-mesenchymal transition with Met
inhibitors reverts chemoresistance in small cell lung cancer. Clin
Cancer Res. 20:938–950. 2014. View Article : Google Scholar
|
|
33
|
Lamouille S and Derynck R: Cell size and
invasion in TGF-beta-induced epithelial to mesenchymal transition
is regulated by activation of the mTOR pathway. J Cell Biol.
178:437–451. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maru S, Ishigaki Y, Shinohara N, Takata T,
Tomosugi N and Nonomura K: Inhibition of mTORC2 but not mTORC1
up-regulates E-cadherin expression and inhibits cell motility by
blocking HIF-2α expression in human renal cell carcinoma. J Urol.
189:1921–1929. 2013. View Article : Google Scholar
|
|
35
|
Kim EY, Kim A, Kim SK, Kim HJ, Chang J,
Ahn CM and Chang YS: Inhibition of mTORC1 induces loss of
E-cadherin through AKT/GSK-3β signaling-mediated upregulation of
E-cadherin repressor complexes in non-small cell lung cancer cells.
Respir Res. 15:262014. View Article : Google Scholar
|
|
36
|
Shi XP, Miao S, Wu Y, Zhang W, Zhang XF,
Ma HZ, Xin HL, Feng J, Wen AD and Li Y: Resveratrol sensitizes
tamoxifen in antiestrogen-resistant breast cancer cells with
epithelial-mesenchymal transition features. Int J Mol Sci.
14:15655–15668. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Darakhshan S and Ghanbari A: Tranilast
enhances the anti-tumor effects of tamoxifen on human breast cancer
cells in vitro. J Biomed Sci. 20:762013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu G, Yu H, Shi X, Sun L, Zhou Q, Zheng D,
Shi H, Li N, Zhang X and Shao G: Cisplatin sensitivity is enhanced
in non-small cell lung cancer cells by regulating
epithelial-mesenchymal transition through inhibition of eukaryotic
translation initiation factor 5A2. BMC Pulm Med. 14:1742014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kao HF, Chang-Chien PW, Chang WT, Yeh TM
and Wang JY: Propolis inhibits TGF-β1-induced
epithelial-mesenchymal transition in human alveolar epithelial
cells via PPARγ activation. Int Immunopharmacol. 15:565–574. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yoshida T, Ozawa Y, Kimura T, Sato Y,
Kuznetsov G, Xu S, Uesugi M, Agoulnik S, Taylor N, Funahashi Y, et
al: Eribulin mesilate suppresses experimental metastasis of breast
cancer cells by reversing phenotype from epithelial-mesenchymal
transition (EMT) to mesenchymal-epithelial transition (MET) states.
Br J Cancer. 110:1497–1505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saito RA, Watabe T, Horiguchi K, Kohyama
T, Saitoh M, Nagase T and Miyazono K: Thyroid transcription
factor-1 inhibits transforming growth factor-beta-mediated
epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Cancer Res. 69:2783–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Choi T: Dimethyl sulfoxide inhibits
spontaneous oocyte fragmentation and delays inactivation of
maturation promoting factor (MPF) during the prolonged culture of
ovulated murine oocytes in vitro. Cytotechnology. 63:279–284. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Santos NC, Figueira-Coelho J,
Martins-Silva J and Saldanha C: Multidisciplinary utilization of
dimethyl sulfoxide: Pharmacological, cellular, and molecular
aspects. Biochem Pharmacol. 65:1035–1041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Szmant HH: Physical properties of dimethyl
sulfoxide and its function in biological systems. Ann NY Acad Sci.
243:20–23. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pagan R, Sánchez A, Martin I, Llobera M,
Fabregat I and Vilaró S: Effects of growth and differentiation
factors on the epithelial-mesenchymal transition in cultured
neonatal rat hepatocytes. J Hepatol. 31:895–904. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pagan R, Martín I, Llobera M and Vilaró S:
Epithelial-mesenchymal transition of cultured rat neonatal
hepatocytes is differentially regulated in response to epidermal
growth factor and dimethyl sulfoxide. Hepatology. 25:598–606. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu HN, Lee YR, Noh EM, Lee KS, Song EK,
Han MK, Lee YC, Yim CY, Park J, Kim BS, et al: Tumor necrosis
factor-alpha enhances DMSO-induced differentiation of HL-60 cells
through the activation of ERK/MAPK pathway. Int J Hematol.
87:189–194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen L, Gibbons DL, Goswami S, Cortez MA,
Ahn YH, Byers LA, Zhang X, Yi X, Dwyer D, Lin W, et al: Metastasis
is regulated via microRNA-200/ZEB1 axis control of tumour cell
PD-L1 expression and intratumoral immunosuppression. Nat Commun.
5:52412014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Alsuliman A, Colak D, Al-Harazi O, Fitwi
H, Tulbah A, Al-Tweigeri T, Al-Alwan M and Ghebeh H: Bidirectional
crosstalk between PD-L1 expression and epithelial to mesenchymal
transition: Significance in claudin-low breast cancer cells. Mol
Cancer. 14:1492015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ota K, Azuma K, Kawahara A, Hattori S,
Iwama E, Tanizaki J, Harada T, Matsumoto K, Takayama K, Takamori S,
et al: Induction of PD-L1 expression by the EML4-ALK oncoprotein
and downstream signaling pathways in non-small cell lung cancer.
Clin Cancer Res. 21:4014–4021. 2015. View Article : Google Scholar : PubMed/NCBI
|
